Alam Kamran Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$688,507.81

Insider Activity of Alam Kamran

According to the SEC Form 4 filings, Alam Kamran, being in a position of

  1. CHIEF FINANCIAL OFFICER at Taysha Gene Therapies, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 104472 shares for $492,522,
    over all time since 2021-08-18, has bought 0 shares, and sold 239770 shares for $1.34M.

Biography of Alam Kamran

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $492,5223100

Comparison of Insiders on Amount of Buys and Sells

2026-02-04SaleTaysha Gene Therapies, Inc.
TSHA
CHIEF FINANCIAL OFFICER
1,655
0.0007%
$4.52$7,481+20.48%
2026-01-26SaleTaysha Gene Therapies, Inc.
TSHA
CHIEF FINANCIAL OFFICER
23,849
0.0098%
$4.61$109,944+14.41%
2026-01-23SaleTaysha Gene Therapies, Inc.
TSHA
CHIEF FINANCIAL OFFICER
78,968
0.0337%
$4.75$375,098+15.67%
2025-08-21SaleTaysha Gene Therapies, Inc.
TSHA
CHIEF FINANCIAL OFFICER
54,491
0.0228%
$2.85$155,299+72.82%
2023-08-24SaleTaysha Gene Therapies, Inc.
TSHA
Chief Financial Officer
33,000
0.0537%
$2.33$76,890-1.71%
2022-08-23SaleTaysha Gene Therapies, Inc.
TSHA
Chief Financial Officer
3,325
0.0081%
$3.47$11,538-68.01%
2022-08-18SaleTaysha Gene Therapies, Inc.
TSHA
Chief Financial Officer
11,482
0.0271%
$3.75$43,058-71.39%
2021-08-20SaleTaysha Gene Therapies, Inc.
TSHA
Chief Financial Officer
11,840
0.0309%
$16.78$198,649-60.01%
2021-08-19SaleTaysha Gene Therapies, Inc.
TSHA
Chief Financial Officer
9,967
0.0265%
$16.47$164,175-58.29%
2021-08-18SaleTaysha Gene Therapies, Inc.
TSHA
Chief Financial Officer
11,193
0.0301%
$17.35$194,199-59.62%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.